Related Experiment Video

Updated: Jun 4, 2026

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

Inflammatory risk factors and pathologies associated with Alzheimer's disease

M Sastre1, J C Richardson, S M Gentleman

  • 1Centre for Neuroscience, Division of Experimental Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK. m.sastre@imperial.ac.uk

Current Alzheimer Research
|February 25, 2011
PubMed

Insights

Inflammation significantly impacts Alzheimer's disease (AD) progression. Early microglial activation, detected via imaging, correlates with cognitive decline and is influenced by various risk factors.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Inflammatory processes are increasingly recognized as critical drivers of Alzheimer's disease (AD) progression.
  • Microglial activation, a key inflammatory response, is observed in early AD stages, preceding hallmark pathologies and correlating with cognitive deficits.

Purpose of the Study:

  • To review the role of inflammatory processes in Alzheimer's disease (AD) progression.
  • To analyze how various risk factors accelerate neuroinflammation and increase AD risk.
  • To discuss the utility of imaging techniques for detecting glial activation and evaluating anti-inflammatory therapies.

Main Methods:

  • Review of existing literature on neuroinflammation in Alzheimer's disease.
  • Analysis of genetic and drug manipulation studies in AD animal models.
  • Examination of imaging studies investigating microglial activation and cognitive deficits.

Main Results:

  • Neuroinflammation, particularly microglial activation, is an early event in Alzheimer's disease pathogenesis.
  • Risk factors like trauma, stroke, infection, and metabolic diseases exacerbate AD-related inflammation.
  • Imaging techniques offer a means to detect early glial activation and assess therapeutic interventions.

Conclusions:

  • Inflammation is a central component of Alzheimer's disease progression.
  • Understanding the impact of risk factors on neuroinflammation is crucial for AD prevention and treatment.
  • Advanced imaging modalities are vital for early diagnosis and monitoring of anti-inflammatory treatments in AD.

More Related Videos

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke09:45

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...